For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241220:nRST8324Qa&default-theme=true
RNS Number : 8324Q Frontier IP Group plc 20 December 2024
AIM: FIPP
20 December 2024
Frontier IP Group plc
("Frontier IP" or the "Group" or the "Company")
Grant of Options
Frontier IP, a specialist in commercialising intellectual property, announces
that, on 19 December 2024, the Board granted options over a total of 1,000,403
ordinary shares of 10 pence each in the Company ("Ordinary Shares") to certain
Executive Directors and personnel of the Company (the "Options").
The Options have been granted through a combination of:
(i) grants under the Frontier IP Group plc Unapproved Share Option Plan
2021, which includes the terms of the Long-Term Incentive Plan (the "LTIP")
details of which were approved by shareholders at the annual general meeting
of the Group held on 9 December 2022; and
(ii) grants under the Company's approved Company Share Option Plan (the
"CSOP").
A total of 889,775 grants have been made under the terms of the Company's
Unapproved Share Option Plan (the "LTIP Grants"), structured as grants of
nominal cost options and at a price of 10 pence per share. The exercise period
of the LTIP Grants commences on 19 December 2027 and expires on 18 December
2034. Further details on the LTIP and the vesting criteria are set out below.
A total of 110,628 Options have been granted under the CSOP (the "CSOP
Grants") with an exercise price of 28 pence per share, being the closing
mid-market price of an existing ordinary share on 18 December 2024, the
business day prior to the grant date. The exercise period of the CSOP Grants
commences on 19 December 2027 and expires on 18 December 2034.
The Options have been granted as follows:
Name Position Number of grants Number of grants under Total options over Ordinary
under CSOP
Unapproved Share Option Plan
Shares held following grant
Neil Crabb Chief Executive Officer 0 157,114 1,407,237
Jackie McKay Chief Operating Officer 0 113,960 1,010,229
Joanne Stent Chief Financial Officer 0 305,076 305,076
Matthew White Chief Commercialisation Officer 0 125,691 799,818
Other Company personnel 110,628 187,934
Total Options granted 110,628 889,775
The Options have been granted in line with the aim of the Company's
remuneration policy which is to incentivise and reward appropriately in order
to attract and retain the best people in support of the Group's strategy.
Following the grants detailed above, the Company now has a total of 6,284,134
options outstanding over Ordinary Shares, representing 9.12% of the Company's
total issued share capital (as enlarged by the new ordinary shares issued in
respect of the fundraising previously announced by the Company and which are
due to admit to trading on AIM on or around 23 December 2024).
Background and details on LTIP
At the Company's 2022 annual general meeting, the Board received the approval
of shareholders for the terms of the LTIP. The LTIP is based on annual awards
of performance shares, structured as nominal cost options, with vesting linked
70% to net asset value per share and 30% to total shareholder return measured
over 3 financial years.
In order to enable such grants, the terms of the previous unapproved option
plan rules were amended to reflect the terms of the LTIP.
The LTIP rules include:
1. a limit of 15% of issued share capital at time of grant on the number
of shares that have been issued, or transferred out of treasury, on the
exercise of options granted, and in satisfaction of any other awards made
under the share schemes operated by the Company during the period of ten years
ending on the grant date with no limit to the number of nil or nominal cost
awards within the 15% limit; and
2. LTIP participants include the executive directors and other Group
employees; allocations are made annually from an aggregate award pool, which
is limited in size to ensure sufficient shares are available to grant in
future years without exceeding the Group's dilution limit of 15% of issued
share capital over the prior ten years. The LTIP includes an individual grant
limit of 200% of salary in any financial year.
ENQUIRIES
Frontier IP Group Plc T: 020 3968 7815 neil@frontierip.co.uk (mailto:neil@frontierip.co.uk)
Neil Crabb, Chief Executive
M: 07464 546 025
Andrew Johnson, Communications & Investor Relations andrew.johnson@frontierip.co.uk (mailto:andrew.johnson@frontierip.co.uk)
Company website: www.frontierip.co.uk (http://www.frontierip.co.uk/)
Allenby Capital Limited (Nominated Adviser) T: 0203 328 5656
Nick Athanas / George Payne
Singer Capital Markets (Broker) T: 0207 496 3000
Charles Leigh-Pemberton / James Fischer
ABOUT FRONTIER IP
Frontier IP unites science and commerce by identifying strong intellectual
property and accelerating its development through a range of commercialisation
services. A critical part of the Group's work is involving relevant industry
partners at an early stage of development to ensure technology meets real
world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence
income by taking an active involvement in spin-out companies, including
support for fund raising and collaboration with relevant industry partners at
an early stage of development.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely
associated (PCA)
a) Name
Neil Crabb Chief Executive Officer
Jackie McKay Chief Operating Officer
Joanne Stent Chief Financial Officer
Matthew White Chief Commercialisation Officer
2 Reason for the notification
a) Position/status See 1a) above
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Frontier IP Group plc
b) LEI 213800BRYUKQPJWKJ312
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 10p each in Frontier IP Group Plc
Identification code Identification code (ISIN) for Frontier IP Group Plc ordinary shares:
GB00B63PS212
b) Nature of the transaction Grant of Options
c) Price(s) and volume(s) Price: 10 pence
Volumes:
Neil Crabb 157,114
Jackie McKay 113,960
Joanne Stent 305,076
Matthew White 125,691
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 19 December 2024
f) Place of the transaction Outside a trading venue
2
Reason for the notification
a)
Position/status
See 1a) above
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Frontier IP Group plc
b)
LEI
213800BRYUKQPJWKJ312
4
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Options over ordinary shares of 10p each in Frontier IP Group Plc
Identification code (ISIN) for Frontier IP Group Plc ordinary shares:
GB00B63PS212
b)
Nature of the transaction
Grant of Options
c)
Price(s) and volume(s)
Price: 10 pence
Volumes:
Neil Crabb 157,114
Jackie McKay 113,960
Joanne Stent 305,076
Matthew White 125,691
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
19 December 2024
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFFDFWUELSEFE